Gannett Co Inc is a publishing business based in the US. Gannett Co shares (GCI) are listed on the NYSE and all prices are listed in US Dollars. Gannett Co employs 16,300 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $2.91 |
|---|---|
| 52-week range | $2.78 - $7.05 |
| 50-day moving average | $3.66 |
| 200-day moving average | $4.92 |
| Wall St. target price | $587.42 |
| PE ratio | 72.75 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.04 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.91 from 2022-07-01
| 1 week (2022-06-27) | -5.52% |
|---|---|
| 1 month (2022-06-03) | -24.81% |
| 3 months (2022-04-05) | -33.41% |
| 6 months (2022-01-05) | -41.92% |
| 1 year (2021-07-02) | -43.82% |
|---|---|
| 2 years (2020-07-02) | 129.13% |
| 3 years (2019-07-05) | 9.33 |
| 5 years (2017-07-03) | 13.82 |
Valuing Gannett Co stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Gannett Co's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Gannett Co's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 73x. In other words, Gannett Co shares trade at around 73x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Gannett Co's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $443.4 million.
The EBITDA is a measure of a Gannett Co's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.2 billion |
|---|---|
| Operating margin TTM | 8.2% |
| Gross profit TTM | $1.3 billion |
| Return on assets TTM | 5.58% |
| Return on equity TTM | 0.65% |
| Profit margin | 0.14% |
| Book value | $3.61 |
| Market capitalisation | $426.6 million |
TTM: trailing 12 months
We're not expecting Gannett Co to pay a dividend over the next 12 months.
Over the last 12 months, Gannett Co's shares have ranged in value from as little as $2.78 up to $7.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Gannett Co's is 2.3875. This would suggest that Gannett Co's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Gannett Co. , Inc. operates as a media and marketing solutions company in the United States. It operates through two segments, Publishing and Digital Marketing Solutions. The company's principal products include 230 daily print media with total paid circulation of approximately 1. 9 million and Sunday circulation of 2. 2 million; 249 weekly print media with total circulation of approximately 1.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.